GlassScriptPhysician profile
Hassan Sajjad
NPI 1184988453
$1,154.95
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $638 · 2020: $191 · 2021: $243 · 2022: $83.26.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $235.18 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $205.26 | 2019-2021 | |
| Glaxosmithkline, LLC. | $132.36 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $91.33 | 2019-2020 | |
| Mylan Specialty L.P. | $79.65 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $55.16 | 2019-2022 | |
| Genzyme Corporation | $50.00 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.62 | 2020-2021 | |
| Grifols USA, LLC | $38.19 | 2019-2021 | |
| Philips North America LLC | $35.05 | 2019 | |
| Resmed Corp | $26.83 | 2020 | |
| Shire North American Group INC | $24.84 | 2019 | |
| Intuitive Surgical, INC. | $21.62 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $20.64 | 2021 | |
| Pfizer INC. | $18.72 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $17.98 | 2021 | |
| La Jolla Pharmaceutical Company | $17.74 | 2019 | |
| United Therapeutics Corporation | $16.05 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.99 | 2019 | |
| Veran Medical Technologies, INC. | $10.74 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hassan Sajjad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.